Please login to the form below
Concordia
This page shows the latest Concordia news and features for those working in and with pharma, biotech and healthcare.
Concordia accused of overcharging NHS for thyroid drug
Markets Authority (CMA), which says Concordia “abused its dominant position to overcharge the NHS”. ... Concordia said it is “working to better understand the CMA's position and will continue to work constructively to resolve these matters”.
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Pharma deals in September 2015
Transformational deals. The two largest deals announced this month were Cinven's sale of Amdipharm Mercury (AMCo) to Concordia Healthcare and Actelion's move to acquire ZS Pharma, at $3.5bn ... level. AMCo's commercial footprint reaches across 100
-
Medius Deal Watch table for March 2015
J&J divest subsidiary marketing vascular devices. 1, 944. Covis / Concordia.
-
Pharma deals in March 2015
Covis (asset). Concordia. 1.2. 8.2. NR. Hyperion. Horizon. 1.1. 9.6. 35%.
-
Deal Watch table for March 2014
341. Revive Pharmaceuticals/ Concordia Healthcare. Product acquisition. Donnatal, adjunctive therapy for IBS and acute enterocolitis (marketed).
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
-
Account Executive
-
Salary TBC
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
- OTC / Consumer Health PR Account Director
-
profit share, pens, life assurance more
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director, Medical Education
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Account Supervisor
-
Salary TBC
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- Genital herpes vaccine candidate heads for human studies
- Is GSK planning to exit the respiratory business?
- FDA advisors say no to empagliflozin in type 1 diabetes
- AbbVie sells $30bn of bonds ahead of Allergan merger
- Novartis makes case for NASH candidate tropifexor
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- Syneos Health announces partnership with AiCure
- FDA advisors say no to empagliflozin in type 1 diabetes
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Merck acquires pre-clinical biotech Calporta for up to $576m
- World Diabetes Day 2019
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
- Pharmaceutical innovation in the APAC region
- A first-of-its-kind study paints a vivid picture of the APAC region’s future...
- Patient journey mapping: exploring the clinical and the emotional journey
- By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Quick links
Infographics
